Evaluating the COVID-19 Responses of Belgium, Denmark, Germany, the Netherlands, Sweden and the United Kingdom, February-June 2020: A Counterfactual Modelling Study

Author(s)

de Boer PT, Miura F, Lagerweij G, Wallinga J
National Institute for Public Health and the Environment, Bilthoven, UT, Netherlands

OBJECTIVES: Differences in responses to the COVID-19 pandemic among Northwestern European countries have generated extensive discussion. We explore how the impact of the first pandemic wave might have differed, had Belgium, Denmark, Germany, the Netherlands, Sweden and the United Kingdom adopted responses from the other countries, or had it delayed its own response.

METHODS: The time-varying reproduction number Rt for each country was estimated using time-series of laboratory-confirmed COVID-19 deaths. Counterfactual assessment of the impact of responses was conducted by interchanging the reduction in reproduction number by calendar date between countries from March 13th to July 1st, 2020. The impact of a delayed response was evaluated by lagging the time-series of the reproduction number with one day or three days.

RESULTS: The cumulative number of COVID-19 deaths for any of the six countries would have differed substantially, had the response of another country been adopted on the respective calendar date. The order, from the lowest to the highest expected mortality rate, was obtained with the responses of the Netherlands, Belgium, Denmark, the United Kingdom, Germany, and Sweden, with a seven- to twelve-fold difference between the lowest and highest outcome. For the Netherlands, delaying its response by three days resulted in a doubling of the cumulative COVID-19 mortality rate.

CONCLUSIONS: During the fast-growing first COVID-19 wave, small differences in initial epidemiological situations between countries, together with small differences in the timing and effectiveness of adopting COVID-19 response from neighboring countries, result in large variations in mortality rates.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Code

EPH44

Topic

Clinical Outcomes, Epidemiology & Public Health, Methodological & Statistical Research

Topic Subcategory

Comparative Effectiveness or Efficacy, Public Health

Disease

Infectious Disease (non-vaccine), No Additional Disease & Conditions/Specialized Treatment Areas, Vaccines

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×